← FDA DRUG APPROVALS

FDA ANDA · ANDA071143

BETAMETHASONE DIPROPIONATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA071143
TYPE
ANDA
ORIGINAL APPROVAL
1987-06-17
LATEST ACTION
1992-11-09
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

BETAMETHASONE DIPROPIONATEDiscontinued
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · CREAM · TOPICAL

Approval history

1992-11-09Labeling · Supplement 16AP
1991-11-04Labeling · Supplement 14AP
1991-09-10Labeling · Supplement 10AP
1990-12-21Labeling · Supplement 11AP
1990-08-06Manufacturing (CMC) · Supplement 8AP
1989-08-09Manufacturing (CMC) · Supplement 7AP
1989-06-26Manufacturing (CMC) · Supplement 4AP
1989-04-05Labeling · Supplement 6AP
1989-01-23Labeling · Supplement 5AP
1988-04-06Labeling · Supplement 2AP
1988-02-03Manufacturing (CMC) · Supplement 1AP
1987-06-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →